Renninger Robert
SEC insider (Form 3/4/5 filer). CIK 0002037968. CHIEF FINANCIAL OFFICER at LeonaBio, Inc. (LONA). 19 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2026. Located in BOTHELL, WA.
Companies Renninger Robert has filed insider reports for
- LeonaBio, Inc. (LONA): Officer, CHIEF FINANCIAL OFFICER
Renninger Robert
CIK: 0002037968
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LeonaBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Apr 9, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
300K shares- - Mar 4, 2026LONA
LeonaBio, Inc.
SaleDirect906 shares at avg. $5.37$5K - Mar 3, 2026LONA
LeonaBio, Inc.
ExerciseDirect3.9K shares- - Jan 2, 2026ATHA
Athira Pharma, Inc.
SaleDirect297 shares at avg. $6.88$2K - Dec 31, 2025ATHA
Athira Pharma, Inc.
ExerciseDirect1.2K shares- - Dec 24, 2025ATHA
Athira Pharma, Inc.
AwardDirectStock Option (Right to Buy)
34.4K shares- - Nov 18, 2025ATHA
Athira Pharma, Inc.
AwardDirect1K shares at avg. $2.31$2K - Jul 1, 2025ATHA
Athira Pharma, Inc.
SaleDirect2.9K shares at avg. $0.29$850.27 - Jun 30, 2025ATHA
Athira Pharma, Inc.
ExerciseDirect12.4K shares- - May 19, 2025ATHA
Athira Pharma, Inc.
AwardDirect10K shares at avg. $0.23$2K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 9, 2026 | LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 300,000 | - | - | Direct |
| Mar 4, 2026 | LONA LeonaBio, Inc. | Sale | 906 | $5.37 | $4,865 | Direct |
| Mar 3, 2026 | LONA LeonaBio, Inc. | Exercise | 3,900 | - | $0 | Direct |
| Jan 2, 2026 |  ATHA Athira Pharma, Inc. | Sale | 297 | $6.88 | $2,043 | Direct |
| Dec 31, 2025 | ATHA Athira Pharma, Inc. | Exercise | 1,236 | - | $0 | Direct |
| Dec 24, 2025 | ATHA Athira Pharma, Inc. | Award Stock Option (Right to Buy) | 34,358 | - | - | Direct |
| Nov 18, 2025 | ATHA Athira Pharma, Inc. | Award | 1,000 | $2.31 | $2,310 | Direct |
| Jul 1, 2025 | ATHA Athira Pharma, Inc. | Sale | 2,897 | $0.29 | $850 | Direct |
| Jun 30, 2025 | ATHA Athira Pharma, Inc. | Exercise | 12,359 | - | - | Direct |
| May 19, 2025 | ATHA Athira Pharma, Inc. | Award | 10,000 | $0.23 | $2,312 | Direct |
1-10 of 19 transactions